4//SEC Filing
Bunker Kevin D. 4
Accession 0001725160-22-000078
CIK 0001725160other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 5:53 PM ET
Size
10.9 KB
Accession
0001725160-22-000078
Insider Transaction Report
Form 4
Bunker Kevin D.
Chief Operating Officer
Transactions
- Sale
Common Stock
2022-04-11$32.40/sh−300$9,720→ 135,100 total(indirect: See Footnote) - Sale
Common Stock
2022-04-11$30.37/sh−4,600$139,709→ 135,400 total(indirect: See Footnote) - Sale
Common Stock
2022-04-11$33.16/sh−100$3,316→ 135,000 total(indirect: See Footnote)
Holdings
- 764,110
Common Stock
- 350(indirect: As UTMA custodian for sons)
Common Stock
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $30.02 to $30.61. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
- [F4]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $32.00 to $32.84. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001807484
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 5:53 PM ET
- Size
- 10.9 KB